MedPath

Differences Between the Bayley-II and the Bayley-III in Very Preterm Infants at 2 Years

Not Applicable
Completed
Conditions
Infant Development
Interventions
Diagnostic Test: Bayley Scales of Infant Development-II
Diagnostic Test: Bayley Scales of Infant Development-III
Registration Number
NCT01373177
Lead Sponsor
Children's Hospital of Philadelphia
Brief Summary

The objective of this randomized study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III (Bayley-III) are higher than scores on the Bayley Scales of Infant Development-II (BSID-II) in the same group of infants who were born very preterm.

Detailed Description

The objective of this randomized crossover study is to test the hypothesis that scores on the Bayley Scales of Infant Development-III are higher than scores on the Bayley Scales of Infant Development-II in the same group of infants who were born very preterm. First, however, the investigators must demonstrate that significant "learning" does not occur when the tests are administered 4-8 weeks apart. The investigators hypothesize that scores on the Bayley-III will be higher than scores on the BSID-II, irrespective of the order in which the tests are administered.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
119
Inclusion Criteria
  • Birth weight <2000 grams and <32 weeks
  • Corrected age of 18-22 months.
Exclusion Criteria
  • English is not the primary language in the child's home.
  • Parent is unable to give informed consent for research participation.
  • Parent is unable to commit to returning for follow-up testing in 4-8 weeks.
  • Infant has severe medical illness or disability expected to impact his/her ability to participate in testing (ex: blindness, deafness, severe cerebral palsy, autism, tracheostomy).
  • No exclusion for economic status, gender, race or ethnicity.
  • Participation in a RCT that restricts timing and administration of developmental testing.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
BSID-II, then Bayley-IIIBayley Scales of Infant Development-IIReceive BSID-II testing 4-8 weeks before Bayley-III testing
Bayley-III, then BSID-IIBayley Scales of Infant Development-IIReceive Bayley-III testing 4-8 weeks before BSID-II testing
Bayley-III, then BSID-IIBayley Scales of Infant Development-IIIReceive Bayley-III testing 4-8 weeks before BSID-II testing
BSID-II, then Bayley-IIIBayley Scales of Infant Development-IIIReceive BSID-II testing 4-8 weeks before Bayley-III testing
Primary Outcome Measures
NameTimeMethod
The primary outcome is the mean difference between BSID-II Mental Development Index (MDI) and Bayley-III Cognitive Score.18-22 months
Secondary Outcome Measures
NameTimeMethod
The mean difference in scores between time point one and time point two (a measure of learning or training).18-22 months
Mean difference between BSID-II Physical Development Index and Bayley-III Composite Motor Score.18-22 months
Proportion of infants classified as having "developmental delay" (MDI <70 on BSID-II or either Language or Cognitive Score <70 on the Bayley-III).18-22 months

Trial Locations

Locations (1)

The Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath